Zynex, Inc. (ZYXI)
NASDAQ: ZYXI · Real-Time Price · USD
1.500
-0.060 (-3.85%)
At close: Sep 17, 2025, 4:00 PM EDT
1.500
0.00 (0.00%)
After-hours: Sep 17, 2025, 4:10 PM EDT
Zynex Market Cap
Zynex has a market cap or net worth of $45.45 million as of September 17, 2025. Its market cap has decreased by -82.06% in one year.
Market Cap
45.45M
Enterprise Value
102.48M
1-Year Change
-82.06%
Ranking
Category
Stock Price
$1.50
Market Cap Chart
Since February 12, 2019, Zynex's market cap has decreased from $154.40M to $45.45M, a decrease of -70.57%. That is a compound annual growth rate of -16.92%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 47.30M | -81.46% |
| Dec 31, 2024 | 255.10M | -30.90% |
| Dec 29, 2023 | 369.20M | -29.14% |
| Dec 30, 2022 | 521.00M | 50.23% |
| Dec 31, 2021 | 346.80M | -25.83% |
| Dec 31, 2020 | 467.60M | 81.45% |
| Dec 31, 2019 | 257.70M | 66.90% |
| Feb 12, 2019 | 154.40M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.37B |
| Johnson & Johnson | 426.30B |
| AbbVie | 384.33B |
| UnitedHealth Group | 310.66B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 230.72B |